ANXA3 and hepatocellular carcinoma: Annexin A3 (ANXA3), a member of the annexin family of Ca2+-dependent phospholipid-binding proteins, was found to promote aggressive HCC with stem cell-like properties as well as resistance to chemotherapy [107].